Low plasma concentrations of arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis

British Journal of Nutrition

Volumn 97, Issue 5, 2007, Pages 906-911

  Richir, Milan C ^a   Siroen, Michiel P C ^a   van Elburg, Ruurd M ^a   Fetter, Willem P F ^a   Quik, Freeke ^a   Nijveldt, Robert J ^a   Heij, Hugo A ^a   Smith, Bert J ^b   Teerlink, Tom ^a   van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Arginine; Asymmetric dimethylarginine; Dimethylarginine; Necrotizing enterocolitis; Premature infant

Indexed keywords

ANTIBIOTIC AGENT; ARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMINO ACID BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME SUBSTRATE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFANT MORTALITY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; PATHOPHYSIOLOGY; PREMATURITY; PROSPECTIVE STUDY;

ARGININE; CASE-CONTROL STUDIES; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES;

EID: 34147149252     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507669268     Document Type: Article

References (44)

1. Alican I & Kubes P (1996) A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 270, G225-G237.
2. Amin HJ, Zamora SA, McMillan DD, Fick GH, Butzner JD, Parsons HG & Scott RB (2002) Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 140, 425-431.
3. Baylis C & Vallance P (1998) Measurement of nitrite and nitrate levels in plasma and urine - what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 7, 59-62.
4. Becker RM, Wu G, Galanko JA, Chen W, Maynor AR, Bose CL & Rhoads JM (2000) Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 137, 785-793.
5. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L & Brotherton T (1978) Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187, 1-7.
6. Beutler B & Cerami A (1988) Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Annu Rev Biochem 57, 505-518.
7. Bode-Boger SM, Boger RH, Kienke S, Junker W & Frolich JC (1996) Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219, 598-603.
8. Boger RH, Bode-Boger SM, Thiele W, Creutzig A, Alexander K & Frolich JC (1998) Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 32, 1336-1344.
9. Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115 457-469.
10. Closs EI, Basha FZ, Habermeier A & Forstermann U (1997) Interference of L-arginine analogues with L-arginine transport mediated by the y + carrier hCAT-2B. Nitric Oxide 1, 65-73.
11. Di Lorenzo M, Bass J & Krantis A (1995) Use of L-arginine in the treatment of experimental necrotizing enterocolitis. Pediatr Surg 30, 235-240.
12. Dupont C (2003) Protein requirements during the first year of life. Am J Clin Nutr 77, 1544S-1549S.
13. Fan WQ, Smolich JJ, Wild J, Yu VY & Walker AM (1996) Nitric oxide modulates regional blood flow differences in the fetal gastrointestinal tract. Am J Physiol 271, G598-G604.
14. Feuerstein G & Hallenbeck JM (1987) Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol 27, 301-313.
15. Hattori Y, Kasai K & Gross SS (1999) Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am J Physiol 276, H2020-H2028.
16. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG & Gonzalez-Crussi F (2003) Neonatal necrotizing enterocolitis: Clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6, 6-23.
17. Hutcheson IR, Whittle BJ & Boughton-Smith NK (1990) Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101, 815-820.
18. Kimoto M, Tsuji H, Ogawa T & Sasaoka K (1993) Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 300, 657-662.
19. Kimoto M, Whitley GS, Tsuji H & Ogawa T (1995) Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 117, 237-238.
20. Kliegman RM, Walker WA & Yolken RH (1993) Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis. Pediatr Res 34, 701-708.
21. Kubes P (1992) Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 262, G1138-G1142.
22. Mittermayer F, Namiranian K, Pleiner J, Schaller G & Wolzt M (2004) Acute Escherichia coli endotoxaemia decreases the plasma L-arginine/ asymmetrical dimethylarginine ratio in humans. Clin Sci (Lond) 106, 577-581.
23. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S & Imaizumi T (1999) Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation 99, 1141-1146.
24. Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, Ter Wee PM & van Guldener C (2005) Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int 68, 2230-2236.
25. Neu J (1996) Necrotizing enterocolitis: The search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 43, 409-432.
26. Neu J (2005) Neonatal necrotizing enterocolitis: An update. Acta Paediatr Suppl 94, 100-105.
27. Nijveldt RJ, Prins HA, Siroen MP, Rauwerda JA, Teerlink T & van Leeuwen PA (2000) Low arginine plasma levels in patients after thoracoabdominal aortic surgery. Eur J Clin Nutr 54, 615-617.
28. Nijveldt RJ, Siroen MP, Teerlink T, van Lambalgen AA, Rauwerda JA & van Leeuwen PA (2004) Gut and liver handling of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int 24, 510-518.
29. Nijveldt RJ, Teerlink T, van der Hoven B, Siroen MPC, Kuik DJ, Rauwerda JA & van Leeuwen PAM (2003a) Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22, 23-30.
30. Nijveldt RJ, Teerlink T, van Guldener C, Prins HA, van Lambalgen AA, Stehouwer CD, Rauwerda JA & van Leeuwen PA (2003b) Handling of asymmetrical dimethylarginine (ADMA) and symmetrical dimethylarginine (SDMA) by the rat kidney under basal conditions and during endotoxemia. Nephrol Dial Transplant 18, 2542-2550.
31. Schulze F, Lenzen H, Hanefeld C, et al. (2006) Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 152, 493-498.
32. Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC & van Leeuwen PA (2006) The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26, 203-228.
33. Stark ME & Szurszewski JH (1992) Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103, 1928-1949.
34. Teerlink T, Nijveldt RJ, De Jong S & van Leeuwen PA (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Analytical Biochemistry 303, 131-137.
35. Vallance P & Leiper J (2004) Cardiovascular biology of the asymmetric dimethylarginine:dImethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24, 1023-1030.
36. van der Zwet WC, Kaiser AM, van Elburg RM, Berkhof J, Fetter WP, Parlevliet GA & Vandenbroucke-Grauls CM (2005) Nosocomial infections in a Dutch neonatal intensive care unit: Surveillance study with definitions for infection specifically adapted for neonates. J Hosp Infect 61, 300-311.
37. Westerbeek EA, van den BA, Lafeber HN, Knol J, Fetter WP & van Elburg RM (2006) The intestinal bacterial colonisation in preterm infants: A review of the literature. Clin Nutr 25, 361-368.
38. Wu G (1997) Synthesis of citrulline and arginine from proline in enterocytes of postnatal pigs. Am J Physiol 272, G1382-G1390.
39. Wu G, Jaeger LA, Bazer FW & Rhoads JM (2004) Arginine deficiency in preterm infants: Biochemical mechanisms and nutritional implications. J Nutr Biochem 15, 442-451.
40. Wu G & Knabe DA (1995) Arginine synthesis in enterocytes of neonatal pigs. Am J Physiol 269, R621-R629.
41. Wu G & Morris SMJ (1998) Arginine metabolism: Nitric oxide and beyond. Biochem J 336, 1-17.
42. Yudkoff M, Nissim I, Pereira G & Segal S (1984) Urinary excretion of dimethylarginines in premature infants. Biochem Med 32, 242-251.
43. Zamora SA, Amin HJ, McMillan DD, Kubes P, Fick GH, Butzner JD, Parsons HG & Scott RB (1997) Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr 131, 226-232.
44. Zanetti G, Heumann D, Gerain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser MP & Baumgartner JD (1992) Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol 148, 1890-1897.